Concourse Financial Group Securities, Inc. Alterity Therapeutics LTD Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ATHE
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About ALTERITY THERAPEUTICS LTD
- Ticker ATHE
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,114,600
- Market Cap $46.1M
- Description
- Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also...